# Screening Protocol for Genetic Diseases of Allergic Inflammation

> clinical trial · VERIFIED · 2026-07-24

Status: COMPLETED · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: Eosinophilic Disease

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: Eosinophilic Disease
- Primary source: https://clinicaltrials.gov/study/NCT00852943

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.